QT
IOVA icon

Quantbot Technologies’s Iovance Biotherapeutics IOVA Stock Holding History

Quantbot Technologies’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,362
Closed -$5.78K – 1922
2025
Q2 		$5.78K Buy
+3,362
New +$8.37K ﹤0.01% 1556
2025
Q1 		– Sell
-2,097
Closed -$15.5K – 1668
2024
Q4 		$15.5K Buy
+2,097
New +$19.4K ﹤0.01% 1366
2023
Q1 		– Sell
-16,235
Closed -$104K – 1787
2022
Q4 		$104K Sell
16,235
-22,668
-58% -$177K 0.01% 1115
2022
Q3 		$372K Buy
38,903
+27,996
+257% +$323K 0.03% 672
2022
Q2 		$120K Buy
10,907
+5,138
+89% +$67.3K 0.01% 1089
2022
Q1 		$96K Buy
+5,769
New +$89.2K 0.01% 1055
2021
Q4 		– Sell
-2,061
Closed -$50K – 1695
2021
Q3 		$50K Buy
2,061
+816
+66% +$19.2K ﹤0.01% 1109
2021
Q2 		$32K Buy
+1,245
New +$32.4K ﹤0.01% 1153
2021
Q1 		– Sell
-49
Closed -$2K – 1576
2020
Q4 		$2K Buy
+49
New +$1.95K ﹤0.01% 1202
2020
Q3 		– Sell
-74
Closed -$2K – 1457
2020
Q2 		$2K Buy
+74
New +$2.43K ﹤0.01% 1056
2019
Q4 		– Sell
-1,500
Closed -$27K – 1399
2019
Q3 		$27K Buy
1,500
+200
+15% +$4.42K ﹤0.01% 1077
2019
Q2 		$31K Buy
+1,300
New +$19.6K ﹤0.01% 975
2018
Q2 		– Sell
-5,957
Closed -$100K – 1342
2018
Q1 		$100K Buy
+5,957
New +$90.2K 0.01% 850
2015
Q4 		– Sell
-2,600
Closed -$14K – 1218
2015
Q3 		$14K Buy
2,600
+2,300
+767% +$17.9K ﹤0.01% 1052
2015
Q2 		$2K Buy
+300
New +$3.35K ﹤0.01% 1055

Other funds holding IOVA

MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Quantbot Technologies's IOVA Position: Q3 2025 in Review

Quantbot Technologies sold out of Iovance Biotherapeutics (IOVA) in Q3 2025, closing a stake of 3,362 shares — an estimated $5.78K sold.

Quantbot Technologies first reported a position in IOVA in Q2 2015 and held it in 15 quarters. The position peaked at $372K in Q3 2022. 253 funds tracked by Wall St. Rank hold IOVA as of Q3 2025.

  • Quantbot Technologies reported no remaining Iovance Biotherapeutics position as of Q3 2025 after selling out during the quarter.
  • Quantbot Technologies sold 3,362 Iovance Biotherapeutics shares in Q3 2025, an estimated $5.78K.
  • Quantbot Technologies first reported a position in Iovance Biotherapeutics in Q2 2015 and held it in 15 quarters.
  • Quantbot Technologies's Iovance Biotherapeutics position peaked at $372K in Q3 2022.
  • 253 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2025.

Based on Quantbot Technologies's 13F filing for Q3 2025, filed 12 Nov 2025.